Ara 290 and Testosterone Interaction
Ara 290 and Testosterone have an interaction requiring monitoring for interaction with 65% confidence. Both Ara 290 and Testosterone can elevate hematocrit/RBC count. Combined use increases risk of polycythemia and thrombotic events. Monitor CBC regularly — donate blood if hematocrit exceeds 54%. These compounds primarily affect different organ systems.
Compound Profiles
Ara 290
Tissue-Protective Peptide | Innate Repair Receptor Agonist
Activates IRR through EPOR/β-common receptor complex, triggering tissue-protective signaling without erythropoietic effects..
View full profileTestosterone
Anabolic-Androgenic Steroid | Primary Male Sex Hormone
Testosterone exerts its effects primarily through binding to the intracellular androgen receptor (AR), forming a hormone-receptor complex that translocates to the nucleus and modulates gene transcription. This drives protein synthesis in skeletal muscle (anabolic effect), stimulates erythropoietin production in the kidneys to increase red blood cell mass, promotes osteoblast activity and bone mineral density, and regulates libido and cognitive function.
View full profileCombined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take Ara 290 with Testosterone?
Yes, but with caution. Both Ara 290 and Testosterone can elevate hematocrit/RBC count. Combined use increases risk of polycythemia and thrombotic events. Monitor CBC regularly — donate blood if hematocrit exceeds 54%. Regular monitoring is advised.
Is Ara 290 and Testosterone safe together?
Based on pharmacological analysis, this combination is considered monitor. However, shared safety flags include: hematocrit raising, teratogenic. Monitor accordingly.
What are the interactions between Ara 290 and Testosterone?
Both Ara 290 and Testosterone can elevate hematocrit/RBC count. Combined use increases risk of polycythemia and thrombotic events. Monitor CBC regularly — donate blood if hematocrit exceeds 54%. This assessment has 65% confidence and is inferred from pharmacological mechanism analysis.
How should I time Ara 290 and Testosterone?
Ara 290 has a half-life of ~20 minutes (SubQ), ~2 minutes (IV) and Testosterone has a half-life of ~8 days (cypionate). No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.